Volume 43, Issue 10, 7 March 2022

Issue @ A Glance

Personalized antithrombotic treatment of cardiovascular disease: a glimpse into the future based on current knowledge

Filippo Crea

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 925–929, https://doi.org/10.1093/eurheartj/ehac086

• Extract
• View article

CardioPulse

The value of 4D flow MRI in cardiac assessment

Mark Nicholls

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 930–932, https://doi.org/10.1093/eurheartj/ehab487

• Extract
• View article

The long journey of interleukin-1 in acute and recurrent pericarditis

Aldo Bonaventura

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 933–934, https://doi.org/10.1093/eurheartj/ehab529

• Extract
• View article

Patient perspectives: how a quest for better recognition and care united four women from three different continents

Judith Ozkan

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 935–937, https://doi.org/10.1093/eurheartj/ehab556

• Extract
• View article

CardioPulse

Weekly Journal Scan

Give genotype-guided dual antiplatelet therapy a second CHANCE

Giovanna Liuzzo and Carlo Patrono

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 938–939, https://doi.org/10.1093/eurheartj/ehac024

• Extract
• View article

State of the Art Review

Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum

Thomas F Lüscher and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 940–958, https://doi.org/10.1093/eurheartj/ehab642

• Abstracts
• View article

Clinical Research

Editor's Choice

Comparative effects of guided vs. potent P2Y₁₂ inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials

Mattia Galli and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 959–967, https://doi.org/10.1093/eurheartj/ehab836

• Abstracts
• View article
• Supplementary data

Editorial

Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy

Michelle L. O’Donoghue and Nicholas A. Marston

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 968–970, https://doi.org/10.1093/eurheartj/ehac046

• Extract
• View article

Clinical Research

Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis

Andrew P DeFilippis and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 971–981, https://doi.org/10.1093/eurheartj/ehab600

• Abstracts
• View article
• Supplementary data

Editorial

Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango

Artur Fedorowski and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 982–984, https://doi.org/10.1093/eurheartj/ehab710

• Abstract
• View article

Clinical Research

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects

Jack Ansell and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 985–992, https://doi.org/10.1093/eurheartj/ehab637

• Abstracts
• View article

Editorial

Ciraparantag as a potential universal anticoagulant reversal agent

Noel C Chan and Jeffrey I Weitz

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 993–995, https://doi.org/10.1093/eurheartj/ehab706

• Extract
• View article

Clinical Research

Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P₂A₂RC score

Morten Würtz and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 996–1004, https://doi.org/10.1093/eurheartj/ehab785

• Abstracts
• View article
• Supplementary data

Editorial

The CHADS-P₂A₂RC score: ready to guide the selection of treatment?

Julinda Mehilli and Maximilian Winhard

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 1005–1007, https://doi.org/10.1093/eurheartj/ehab864

• Abstract
• View article

Viewpoint

Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?

Sean Tan and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 1008–1011, https://doi.org/10.1093/eurheartj/ehab896

• Abstract
• View article
• Supplementary data

Discussion Forum

Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?

Kai M Eggers and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Page 1012, https://doi.org/10.1093/eurheartj/ehab805

• Extract
• View article

Appropriate criteria for the definition of Type 4a MI

Johanne Silvain and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 1013–1014, https://doi.org/10.1093/eurheartj/ehab808

• Extract
• View article

Cardiovascular Flashlight

When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years

Riwa Nasser and others

European Heart Journal, Volume 43, Issue 10, 7 March 2022, Page 1015, https://doi.org/10.1093/eurheartj/ehab719

• Extract
• View article